Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Avanos Medical Expects Adjusted Diluted EPS Of $1.05-$1.15 For FY23, Vs. Consensus Of $1.52

Author: Benzinga Newsdesk | August 09, 2023 07:22am

For the second half of 2023, Avanos Medical, Inc.(NYSE:AVNS) anticipates low single-digit organic growth, adjusted gross margins greater than 59% 

Posted In: AVNS

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist